Search

everythinglearnresearchcommunity

for

Search:↓

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Plant-based products can improve hair and skin health without harmful side effects.

Early diagnosis and treatment, like topical minoxidil, can prevent hair loss in children.

Ziziphus jujuba and Eclipta alba leaf extracts improve blood sugar levels and cognitive function in diabetic rats.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Hair loss is common in IBD patients, and some medications may lower the risk.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Green tea may help with health issues like cancer, heart disease, and weight loss due to its high catechin content.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Women with PCOS tend to be less optimistic than those without it.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Alopecia areata involves immune response and gene changes affecting hair loss.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Ziziphus spina-christi leaf extract lowered blood sugar and protected organs in diabetic rats.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Certain genes influence immunoglobulin levels in Chinese Holstein cows, which can improve calf health.

Selective breeding can enhance immunity in dairy cattle.